Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M271Revenue (TTM) $M10.2Net Margin (%)-1,080.2Altman Z-Score-0.4
Enterprise Value $M185EPS (TTM) $-2.8Operating Margin %-1,062.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score-1.3Pre-tax Margin (%)-1,080.2Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %-15.2Quick Ratio7.2Cash flow > EarningsY
Price/Sales20.95-y EBITDA Growth Rate %-4.8Current Ratio7.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-77.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-92.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M48.8ROIC % (ttm)-3,420.9Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

DVAX is held by these investors:



DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Janssen RobertVice President 2017-01-24Buy6,000$4.0436.14view
Janssen RobertVice President 2016-06-28Buy1,452$13.68-59.8view
Gray EddieCEO and Director 2016-05-20Buy2,750$15.57-64.68view
Janssen RobertVice President 2016-05-12Buy1,000$15.12-63.62view
Janssen RobertVice President 2015-10-08Buy100$23.34-76.44view
Gray EddieCEO and Director 2014-08-14Buy2,500$14.9-63.09view
KISNER DANIEL LDirector 2013-10-30Buy1,000$10.8-49.07view
ORONSKY ARNOLD LDirector 2013-10-30Buy18,605$10.8-49.07view
Phillips Peggy VDirector 2013-10-30Buy9,302$10.8-49.07view
Janssen RobertChief Medical Officer and VP 2013-07-09Sell0$0-49.07view

Press Releases about DVAX :

Quarterly/Annual Reports about DVAX:

News about DVAX:

Articles On GuruFocus.com
What Dynavax Technologies Holders Need to Consider Heading Into the Heplisav-B PDUFA Apr 03 2017 
Trump Victory Gives Life to Pharma,Biotech - Take a Look at VBI Vaccines Nov 11 2016 
Steven Cohen Increases Position in Dynavax Oct 07 2016 
VBI Vaccines: The Safer Alternative to the Struggling Dynavax Technologies Sep 06 2016 
Dynavax Initiates Immuno-Oncology Clinical Trial Evaluating SD-101 in Combination With Merck's Anti- Oct 08 2015 
Dynavax to Participate in Two Upcoming Investor Conferences Sep 03 2015 
Dynavax Reports Second Quarter 2015 Financial Results Aug 07 2015 
Dynavax Prices Public Offering of Common Stock Jul 22 2015 
Dynavax Announces Proposed Public Offering of Common Stock Jul 21 2015 
Dynavax Secures $40 Million Credit Facility With Hercules Technology Growth Capital Dec 29 2014 

More From Other Websites
Dynavax to Present Data on SD-101 in Combination with KEYTRUDA(R) at the 2017 American Society of... May 19 2017
ETFs with exposure to Dynavax Technologies Corp. : May 11, 2017 May 11 2017
Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 May 10 2017
Dynavax Technologies reports 1Q loss May 08 2017
Dynavax Reports First Quarter 2017 Financial Results May 08 2017
ETFs with exposure to Dynavax Technologies Corp. : April 21, 2017 Apr 21 2017
William Blair Assigns 70% Probability of Approval to Dynavax's Heplisav Apr 07 2017
What Dynavax Technologies Holders Need to Consider Heading Into the Heplisav-B PDUFA Apr 03 2017
Why Dynavax Technologies Corporation Stock Briefly Spiked Today Apr 03 2017
Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B Apr 03 2017
ETFs with exposure to Dynavax Technologies Corp. : March 27, 2017 Mar 27 2017
Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017 Mar 23 2017
Dynavax Announces Upcoming Data Presentations for Three TLR9 Agonist Programs at the 2017 American... Mar 20 2017
Dynavax Reports Fourth Quarter and Year End 2016 Financial Results and Company Update Mar 13 2017
3 Beaten Down Stocks Ready to Bounce Back Mar 09 2017
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle Mar 08 2017
UPDATE: Dynavax shares reverse premarket losses to open flat Mar 06 2017
Dynavax Presents Promising Clinical Data from Lead Immuno-Oncology Candidate, SD-101, at the... Mar 06 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat